PATENT CLAIM ANALYSIS

Application Number: 16119263
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "263220"]

Abstract:
The invention discloses compositions comprising BRaf inhibitors and uses thereof for treating and/or preventing by topical or systemic administration cutaneous conditions caused by treatment with EGFR inhibitors and/or PI3K inhibitors.

Claim (Index 11):
A pharmaceutical composition for treating or preventing a cutaneous condition in a subject in need thereof, the composition comprising a therapeutically effective amount of a BRaf inhibitor and a pharmaceutically acceptable carrier, wherein the cutaneous condition is associated with treatment with an EGFR inhibitor and/or a PI3K inhibitor.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.14815
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15002457', '12865620', '14147689', '14770994', '15105904']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7413825663961823
- 35 USC 102 Novelty (BERT): 0.5276093004347464
- Combined Prediction Score: 0.7200052398000386
- Mean Citation Score: 302.35572
- Max Citation Score: 316.7195700000001
- Similarity Product: 211.8092480130601

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test